Neuralink to scale up brain chip production in 2026
Note: AI technology was used to generate this article’s audio.
- Neuralink to begin large-scale production of brain-computer interface chips in 2026.
- Chips already help patients with paralysis control devices and interact digitally.
Elon Musk announced on X that his company Neuralink will start large-scale production of its brain-computer interface (BCI) chips and transition to fully automated surgical procedures in 2026.
Helping patients with paralysis
The chips are designed to assist people with conditions such as spinal cord injuries. The first patient implanted with the chip has been able to play video games, browse the internet, post on social media, and move a computer cursor using only brain signals.
Neuralink began human trials in 2024 after addressing safety concerns raised by the US Food and Drug Administration, which had previously rejected the company’s application in 2022.
Global trials and funding
By September 2025, 12 patients worldwide with severe paralysis had received implants, allowing them to control digital and physical tools via brain signals.
The company also secured $650 million in a funding round in June 2025 to support production scale-up and further development.
Looking ahead
Neuralink plans to automate surgical procedures for chip implantation, aiming to make the technology safer and more widely available to patients with mobility impairments.
